TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Turnover |
63,153
|
41,014
|
239,462 |
| Financial expenses |
11,273
|
26,569
|
26,995 |
| Earnings before taxes |
2,754
|
-229,318
|
-217,468 |
| EBITDA |
14,047
|
-225,455
|
-189,191 |
| Total assets |
458,940
|
591,321
|
250,060 |
| Current assets |
49,335
|
52,227
|
172,067 |
| Current liabilities |
178,767
|
304,412
|
159,976 |
| Equity capital |
280,173
|
286,909
|
-94,823 |
| - share capital |
2,006
|
2,074
|
2,064 |
| Employees (average) |
2
|
2
|
84 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Solvency |
61.0%
|
48.5%
|
-37.9% |
| Turnover per employee |
31,576
|
20,507
|
2,851 |
| Profit as a percentage of turnover |
4.4%
|
-559.1%
|
-90.8% |
| Return on assets (ROA) |
3.1%
|
-34.3%
|
-76.2% |
| Current ratio |
27.6%
|
17.2%
|
107.6% |
| Return on equity (ROE) |
1.0%
|
-79.9%
|
229.3% |
| Change turnover |
23,495
|
-199,681
|
112,649 |
| Change turnover % | 59% | 89% | |
| Chg. No. of employees |
0
|
-82
|
35 |
| Chg. No. of employees % | 0% | 71% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.